Acumen Pharmaceuticals Inc (ABOS)

Acumen Pharmaceuticals Inc Azioni (ABOS) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	3.85% 17.77	18.49	16.04	13.48	13.13
Interest Income/Expense	1.00	-	-	-	-
Operating Income/Loss	3.85% -17.77	-18.49	-16.04	-13.48	-13.13
Nonoperating Income/Loss	45.85% 2.901	1.989	3.082	1.868	1.828
Income/Loss From Continuing Operations Before Tax	9.84% -14.87	-16.50	-12.96	-11.61	-11.31
Income/Loss From Continuing Operations After Tax	9.84% -14.87	-16.50	-12.96	-11.61	-11.31
Net Income/Loss	9.84% -14.87	-16.50	-12.96	-11.61	-11.31
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,808% 59.81	3.1344	54.23	41.03	41.03
Diluted Average Shares	1,808% 59.81	3.1344	54.23	41.03	41.03
Basic Earnings Per Share	13.79% -0.25	-0.29	-0.24	-0.28	-0.28
Diluted Earnings Per Share	13.79% -0.25	-0.29	-0.24	-0.28	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-